Back to results
US 5,654,151 AGranted
High affinity HIV Nucleocapsid nucleic acid ligands
AssigneeNeXstar Pharmaceuticals, Inc.
InventorsPatrick Nikita Allen, Larry Gold
Life of this patent
Estimating the term…
Abstract
Methods are described for the identification and preparation of high-affinity nucleic acid ligands to HIV-1 nucleocapsid. Included in the invention are specific RNA ligands to HIV-1 nucleocapsid identified by the SELEX method. Also included are RNA ligands that inhibit the function of HIV-1 nucleocapsid.
Claims8
A method for identifying nucleic acid ligands to nucleocapsid comprising:
- a) preparing a candidate mixture of nucleic acids;
- b) contacting the candidate mixture of nucleic acids with nucleocapsid, wherein nucleic acids having an increased affinity to nucleocapsid relative to the candidate mixture may by partitioned from the remainder of the candidate mixture;
- c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture;
- and
- d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acid sequences with relatively higher affinity and specificity for binding to nucleocapsid, whereby nucleic acid ligands of nucleocapsid may be identified.
2 more elements
Dependencies are inferred from the claim text.